Adagene Inc.
ANTI-CD137 MOLECULES AND USE THEREOF

Last updated:

Abstract:

The present disclosure provides antibodies that bind to human CD137 or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, and for the treatment of cancer.

Status:
Application
Type:

Utility

Filling date:

28 Dec 2021

Issue date:

30 Jun 2022